Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 821 to 830 of 5620 Results
July 01, 2022
GSK to acquire Sierra Oncology
$1.9 Billion
July 01, 2022
Sale of AllCells to Discovery Life Scienes
Undisclosed
June 30, 2022
eir and InfraVia announce a partnership aimed at accelerating fibre-to-the-home roll-out across Ireland
Undisclosed
June 30, 2022
Equistone realises Fund V investment in Sicame through inaugural continuation fund deal
Undisclosed
June 30, 2022
The French specialty pharmaceutical company Juvisé Pharmaceuticals has successfully completed a €400M refinancing following the acquisition of the worldwide rights of Pylera®, an antimicrobial tri-therapy indicated for gastro-intestinal Helicobacter pylori infections
$418 Million
June 30, 2022
RINA to strategically review its capital structure, refinancing the existing c. €145m indebtedness and securing new resources for c. €170m to unlock future growth
Undisclosed
June 30, 2022
Groupe Colisée and Primonial REIM strengthen their privileged relationship around a portfolio of 5 residences in France
Undisclosed
June 29, 2022
UniCredit and Prelios sign partnership for management of Unlikely-To Pay loans
Undisclosed
June 28, 2022
Tivity Health announces definitive agreement to be acquired by Stone Point Capital for $32.50 per share in cash
$2 Billion
June 28, 2022